维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Hines RN"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria显示文摘	Cashman JR Camp K Fakharzadeh SS Fennessey PV Hines RN Mamer OA	2003	Curr Drug Metab2003，4，2：	1
2	Discovery of novel flavin-containing monooxygenase 3 (FMO3) single nucleotide polymorphisms and functional analysis of upstream haplotype variants显示文摘	Koukouritaki SB Poch MT Cabacungan ET McCarver DG Hines RN	2005	Mol Pharmacol2005，68，2：	1
3	Mechanisms regulating human FMO3 transcription显示文摘	Klick DE Hines RN	2007	Drug Metab Rev2007，39，23：	1
4	Developmental expression of the major human hepatic CYP3A enzymes显示文摘	Stevens JC Hines RN Gu C	2003	J Pharmacol Exp Ther2003，307，2：	1
5	The ontogeny of human drug-metabolizing enzymes: phase II conjunction enzymes and regulatory mechanisms显示文摘	McCarver DG Hines RN	2002	J Pharmacol Exp Ther2002，300，：	1
6	Epirubicin glucuronidation and UGT2B7 developmental expression显示文摘	Zaya MJ Hines RN Stevens JC		0，，：	1
7	The ontogeny of human drug - metabolizing enzymes:phase Ⅱ conjugation enzymes and regulatory mechanisms 显示文摘	McCarver DG Hines RN	2008	Pharmacol Exp Ther2008，300，2：	1
8	Developmental expression of drug metabolizing enzymes:impact on disposition in neonates and young children显示文摘	Hines RN		0，，1：	1
9	The ontogeny of human drug-metabolizing enzymes:phaseⅡconjugation enzymes and regulatory mechanisms显示文摘	Mc Carver DG Hines RN	2002	J Pharmacol Exp Ther2002，300，2：	1
10	The ontogeny of drug metabolism enzymes and implications for adverse drug events显示文摘	Hines RN	2008	Pharmacol Ther2008，118，2：	1
11	Genetics and susceptibility to toxic chemicals: do you (or should you) know your genetic profile? 显示文摘	LASH LH HINES RN GONZALEZ FJ	2003	J Pharmacol Exp Ther2003，305，2：	1
12	A genetic polymorphism in the regulatory sequences of human CYP2E1:association with increased chlorzoxazone hydroxylation in the prensence of obesity and ethanol intake显示文摘	Byun R Hines RN	1998	Toxicol Appl Pharmacol1998，152，：	1
13	Ontogeny of human hepatic cytochromes P450显示文摘	Hines RN	2007	J Biochem Mol Toxicol2007，21，4：	1
14	Genetic variability at the human FMO1 locus: significance of a basal promoter yin yang 1 element polymorphism (FMO1*6)显示文摘	Luo Z Hopp KA	2003	J Pharmacol Exp Ther2003，306，3：	1
15	Use of and occupational exposure to indium in the United States 显示文摘	Hines C J Roberts JL Andrews RN	2013	J Occup Environ Hyg2013，10，12：	1
16	The ontogeny of human drug-metabo- lizing enzymes: phase I oxidative enzymes 显示文摘	Hines RN McCarver DG	2002	J Pharmacol Exp Ther2002，300，2：	1
17	The ontogeny of drug metabolism enzymes and im- plications for adverse drug events 显示文摘	Hines RN	2008	Pharmacol Ther2008，118，2：	1
18	Functional characterization of the human CYP1A1 negative regulatory element :modulation of Ah receptor mediated transcriptional activity显示文摘	Piechocki MP Hines RN	1998	Carcinogenesis1998，19，：	1
19	Trichloroethylene decreases heat shock protein 90 interactions with endothelial nitric oxide synthase: implications for endothelial cell proliferation显示文摘	Ou J Ou Z McCarver DG Hines RN Oldham KT Ackerman AW	2003	Toxicol Sci2003，73，1：	1
20	The mammalian flavin-containing monooxygenases: molecular characterization and regulation of expression显示文摘	Hines RN Cashman JR Philpot RM Williams DE Ziegler DM	1994	Toxicol Appl Pharmacol1994，125，1：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示